SCHEMBL22909587

SCHEMBL22909587

CCOC(=O)[C@@H](N)CCC(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NOS2 P35228 3/20 0.37
NOS3 P29474 2/20 0.37
NOS1 P29475 2/20 0.37
NOD1 Q9Y239 2/20 0.36
ALDH1A1 P00352 3/20 0.36
CPB2 Q96IY4 2/20 0.35
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HTT P42858 1/20 0.33
POLB P06746 1/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
HPGD P15428 1/20 0.33
SOAT1 P35610 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28271057 1.00 ALOX15 (0.38) ALOX15CYP2D6CYP2C9CYP2C19NOS2
SCHEMBL28269212 0.92 NOD1 (0.40) ALOX15CYP2D6CYP2C9CYP2C19NOS2
SCHEMBL28269197 0.89 NOD1 (0.39) ALOX15CYP2D6CYP2C9CYP2C19NOS2
SCHEMBL31054715 0.85 CPB2 (0.35) ALOX15CYP2D6CYP2C9CYP2C19NOS2
SCHEMBL17282100 0.84 CPB2 (0.39) ALOX15CYP2D6CYP2C9CYP2C19NOD1
SCHEMBL1176235 0.83 ALOX15 (0.48) ALOX15CYP2D6CYP2C9CYP2C19NOD1
SCHEMBL206673 0.82 CA1 (0.38) NOS2NOS3NOS1HTT
SCHEMBL1068024 0.82 CA1 (0.38) NOS2NOS3NOS1HTT
SCHEMBL1688567 0.82 ALOX15 (0.39) ALOX15CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL17202872 0.81 ALOX15 (0.42) ALOX15CYP2D6CYP2C9CYP2C19NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11339193-B2 CDP protein secretion inhibitors KEZAR LIFE SCIENCES (US) 2022-05-24 US disclosed
US-20210017233-A1 CDP PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2021-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11339193-B2 CDP protein secretion inhibitors SEC61G, SEC61A1, SEC61B ALOX15 3697/4885CYP2D6 3723/4885CYP2C9 4091/4885
US-20210017233-A1 CDP PROTEIN SECRETION INHIBITORS SEC61G, SEC61A1, SEC61B ALOX15 3697/4885CYP2D6 3723/4885CYP2C9 4091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.